Women who take Zoloft during pregnancy may give birth to babies with potentially crippling or even fatal heart and lung ailments, studies have shown.
A safety announcement has been issued about Zoloft and the generic equivalent setraline – a selective serotonin reuptake inhibitor (SSRI) antidepressant – by the U.S. Food and Drug Administration (FDA) over the risk of heart defects and a lung condition known as persistent pulmonary hypertension of the newborn, or PPHN.
PPHN occurs when an infant does not adapt to breathing outside the womb and, in severe cases, can result in heart failure, seizures, multiple organ failure, brain damage, and death.
If you used Zoloft or setraline and your baby suffered a PPHN or a heart defect, including the condition known as a "hole in the heart," you should contact a Zoloft attorney for a free evaluation of a potential Zoloft lawsuit.
The FDA initially cautioned patients about SSRI anti-depressants such as Zoloft, manufactured by Pfizer, in 2006 based on a study that showed mothers who used the drugs were six times more likely to give birth to babies suffering from PPHN.
The FDA again issued a warning in December 2011 after new studies presented conflicting findings, though one in 2009 showed an increased risk of septal heart defects in newborns while another in 2010 showed more evidence of a link between SSRIs and heart defects.
Almost 100 lawsuits have been filed by women who took Zoloft on claims of birth defects, with cases in multidistrict litigation in the U.S. District Court for the Eastern District of Pennsylvania.
Kline & Specter, PC, is no longer accepting Zoloft/SSRI birth defect claims.